Literature DB >> 11916518

C/EBP-beta, C/EBP-delta, PU.1, AML1 genes: mutational analysis in 381 samples of hematopoietic and solid malignancies.

Vijaya Vegesna1, Seisho Takeuchi, Wolf-K Hofmann, Takayuki Ikezoe, Sigal Tavor, Utz Krug, Anthony C Fermin, Anthony Heaney, Carl W Miller, H Phillip Koeffler.   

Abstract

Mutations of transcription factors are associated with the pathogenesis of cancer. Genomic DNA from 381 cancers and cell lines representing leukemias, lymphomas and a variety of solid tumors were examined for mutations of genes coding for the C/EBP-beta, C/EBP-alpha, PU.1, and AML1 transcription factors using single strand conformation polymorphism (SSCP) and direct DNA sequencing. Mutation of C/EBP-beta (a chronic myelogenous leukemia cell line, Kcl22) and C/EBP-delta (a Burkitt's lymphoma cell line, Raji) were found. Interestingly, the sample with a C/EBP-beta alterations had two missense (P236L and G252A) and two silent mutations in a highly conserved region of the gene. The C/EBP-delta alteration in Raji was a missense mutation (A177G). These findings suggest that mutations of the C/EBP-beta, C/EBP-delta, PU.1, and AML1 rarely contribute to the development of hematopoietic or solid cancers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916518     DOI: 10.1016/s0145-2126(01)00150-3

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  17 in total

1.  RUNX1 regulates corepressor interactions of PU.1.

Authors:  Zhenbo Hu; Xiaorong Gu; Kristine Baraoidan; Vinzon Ibanez; Arun Sharma; ShriHari Kadkol; Reinhold Munker; Steven Ackerman; Giuseppina Nucifora; Yogen Saunthararajah
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

2.  Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.

Authors:  Matthew J Walter; John S Park; Rhonda E Ries; Steven K M Lau; Michael McLellan; Sara Jaeger; Richard K Wilson; Elaine R Mardis; Timothy J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-19       Impact factor: 11.205

3.  Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia.

Authors:  Donald Metcalf; Aleksandar Dakic; Sandra Mifsud; Ladina Di Rago; Li Wu; Stephen Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

4.  Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBPbeta-deficient hematopoietic cells.

Authors:  Tadayuki Akagi; Takayuki Saitoh; James O'Kelly; Shizuo Akira; Adrian F Gombart; H Phillip Koeffler
Journal:  Blood       Date:  2007-12-04       Impact factor: 22.113

5.  Eicosapentaenoic acid demethylates a single CpG that mediates expression of tumor suppressor CCAAT/enhancer-binding protein delta in U937 leukemia cells.

Authors:  Veronica Ceccarelli; Serena Racanicchi; Maria Paola Martelli; Giuseppe Nocentini; Katia Fettucciari; Carlo Riccardi; Pierfrancesco Marconi; Paolo Di Nardo; Francesco Grignani; Luciano Binaglia; Alba Vecchini
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

Review 6.  Deregulated transcription factors in leukemia.

Authors:  Yutaka Shima; Issay Kitabayashi
Journal:  Int J Hematol       Date:  2011-08-09       Impact factor: 2.490

7.  Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.

Authors:  Junling Si; Xueyan Yu; Yingjie Zhang; James W DeWille
Journal:  Mol Cancer       Date:  2010-04-28       Impact factor: 27.401

Review 8.  CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases.

Authors:  Cynthia A Zahnow
Journal:  Expert Rev Mol Med       Date:  2009-04-08       Impact factor: 5.600

Review 9.  The role of C/EBPbeta in mammary gland development and breast cancer.

Authors:  Sandra L Grimm; Jeffrey M Rosen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

10.  The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias.

Authors:  Vincent-Philippe Lavallée; Irène Baccelli; Jana Krosl; Brian Wilhelm; Frédéric Barabé; Patrick Gendron; Geneviève Boucher; Sébastien Lemieux; Anne Marinier; Sylvain Meloche; Josée Hébert; Guy Sauvageau
Journal:  Nat Genet       Date:  2015-08-03       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.